Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!
Icon (NASDAQ:ICLR) had its price target decreased by Citigroup from $185.00 to $160.00 in a research report sent to investors on Thursday, BenzingaRatingsTable reports. Citigroup currently has a neutr
Shares of Icon Plc (NASDAQ:ICLR) have been given a consensus rating of “Hold” by the thirteen ratings firms that are covering the stock, Marketbeat reports. One investment analyst has rated the st
Ladenburg Thalmann Financial Services Inc. grew its position in shares of Icon Plc (NASDAQ:ICLR) by 39.2% in the 4th quarter, according to the company in its most recent Form 13F filing with the Secur
Diversified Trust Co decreased its holdings in Icon Plc (NASDAQ:ICLR) by 1.9% in the 1st quarter, HoldingsChannel reports. The firm owned 7,602 shares of the medical research company’s stock after s
Icon (NASDAQ:ICLR) was downgraded by Zacks Investment Research from a “hold” rating to a “sell” rating in a research note issued to investors on Saturday, Zacks.com reports. According to Zacks
When you buy shares in a company, it's worth keeping in mind the possibility that it could fail, and you could lose...
Dalton Greiner Hartman Maher & Co. purchased a new stake in shares of Icon Plc (NASDAQ:ICLR) in the first quarter, according to the company in its most recent filing with the SEC. The firm purchased 3
Coastal Capital Group Inc. lessened its stake in Icon Plc (NASDAQ:ICLR) by 44.7% in the first quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission.
Icon Plc (NASDAQ:ICLR) – Research analysts at SunTrust Banks reduced their Q2 2020 earnings per share (EPS) estimates for Icon in a report issued on Monday, April 6th. SunTrust Banks analyst S. Drap
Goldman Sachs Group Inc. raised its holdings in Icon Plc (NASDAQ:ICLR) by 40.4% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Co
Icon (NASDAQ:ICLR) was upgraded by stock analysts at BidaskClub from a “hold” rating to a “buy” rating in a report issued on Thursday, BidAskClub reports. ICLR has been the subject of several
ICON plc, (NASDAQ: ICLR) a global provider of drug development and commercialisation services to the pharmaceutical, biotechnology and medical device industries, has won awards across multiple categor
Icon Plc (NASDAQ:ICLR) – Investment analysts at SunTrust Banks cut their Q1 2020 EPS estimates for shares of Icon in a research report issued on Monday, April 6th. SunTrust Banks analyst S. Draper n
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE